The explorative clinical trial of a HPV therapeutic vaccine using lactobacillus to Cervical Intraepithelial Neoplasia 3 (CIN3).

Trial Profile

The explorative clinical trial of a HPV therapeutic vaccine using lactobacillus to Cervical Intraepithelial Neoplasia 3 (CIN3).

Completed
Phase of Trial: Phase I

Latest Information Update: 13 May 2016

At a glance

  • Drugs Human papillomavirus vaccine (Primary)
  • Indications Cervical cancer; Cervical dysplasia; Cervical intraepithelial neoplasia; Human papillomavirus infections
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 13 Feb 2012 Result were presented in an AnGes MG media release.
    • 29 Nov 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top